Purple Biotech Ltd.PPBTNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -900.00% |
| Q2 2025 | -122.22% |
| Q1 2025 | 10.00% |
| Q4 2024 | 47.37% |
| Q3 2024 | 78.16% |
| Q2 2024 | 37.41% |
| Q1 2024 | 25.67% |
| Q4 2023 | 19.05% |
| Q3 2023 | 5.71% |
| Q2 2023 | 0.41% |
| Q1 2023 | 24.77% |
| Q4 2022 | -22.47% |
| Q3 2022 | -35.53% |
| Q2 2022 | 51.95% |
| Q1 2022 | -64.00% |
| Q4 2021 | -39.66% |
| Q3 2021 | 13.53% |
| Q2 2021 | 45.09% |
| Q1 2021 | -195.44% |
| Q4 2020 | -76.76% |
| Q3 2020 | 173.91% |
| Q2 2020 | 0.00% |
| Q1 2020 | -291.16% |
| Q4 2019 | 29.75% |
| Q3 2019 | -24.74% |
| Q2 2019 | 0.00% |
| Q1 2019 | -521.30% |
| Q4 2018 | 0.00% |
| Q3 2018 | 94.60% |
| Q2 2018 | 0.00% |
| Q1 2018 | 33.33% |
| Q4 2017 | 0.00% |
| Q3 2017 | 16.67% |
| Q2 2017 | 0.00% |
| Q1 2017 | 40.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | -53.85% |
| Q2 2016 | 0.00% |
| Q1 2016 | 30.36% |
| Q4 2015 | 71.13% |